The elaboration of a highly specific tool, such as an antibody, generated against the TRPV6 channel extracellular domain, would allow to specifically target and stop TRPV6-expressing cancer cells by limiting the ability of cancer cells to employ overexpressed TRPV6 channels for proliferation and viability and/or by inducing cell suppression pathways. This evidence concerns the gene TRPV6 and cancer.